• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>American Journal of Physiology >NF-κB blockade during short-term l-NAME and salt overload strongly attenuates the late development of chronic kidney disease
【24h】

NF-κB blockade during short-term l-NAME and salt overload strongly attenuates the late development of chronic kidney disease

机译：NF-κB blockade during short-term l-NAME and salt overload strongly attenuates the late development of chronic kidney disease

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相关主题

摘要

Oliveira KC, Zambom FFF, Albino AH, Alarcon Arias SC, Avila VF, Faustino VD, Malheiros DMAC, Camara NOS, Fujihara CK, Zatz R. NF-κB blockade during short-term l-NAME and salt overload strongly attenuates the late development of chronic kidney disease. Am J Physiol Renal Physiol 319: F215-F228, 2020. First published May 28, 2020; doi:10.1152/ajprenal.00495.2019.— Nitric oxide synthase inhibition by N~ω-nitro-L-arginine methyl ester (l-NAME) plus a high-salt diet (HS) is a model of chronic kidney disease (CKD) characterized by marked hypertension and renal injury. With cessation of treatment, most of these changes subside, but progressive renal injury develops, associated with persistent low-grade renal inflammation. We investigated whether innate immunity, and in particular the NF-κB system, is involved in this process. Male Munich-Wistar rats received HS + l-NAME (32 mg.kg~-1.day~-1), whereas control rats received HS only. Treatment was ceased after week 4 when 30 rats were studied. Additional rats were studied at week 8(n = 30) and week 28 (n = 30). As expected, HS + l-NAME promoted severe hypertension, albuminuria, and renal injury after 4 wk of treatment, whereas innate immunity activation was evident. After discontinuation of treatments, partial regression of renal injury and inflammation occurred, along with persistence of innate immunity activation at week 8. At week 28, glomerular injury worsened, while renal inflammation persisted and renal innate immunity remained activated. Temporary administration of the NF-κB inhibitor pyrroli-dine dithiocarbamate, in concomitancy with the early 4-wk HS + l-NAME treatment, prevented the development of late renal injury and inflammation, an effect that lasted until the end of the study. Early activation of innate immunity may be crucial to the initiation of renal injury in the HS + l-NAME model and to the autonomous progression of chronic nephropathy even after cessation of the original insult. This behavior may be common to other conditions leading to CKD.

著录项

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号